NAD Recommends Ganeden Change Claims With FDA’s Label Decision Pending
This article was originally published in The Tan Sheet
Executive Summary
Ganeden Biotech should stop using certain testimonials and claims for some Digestive Advantage products, but whether it should market products in the line as "medical foods" is up to FDA to decide, according to the National Advertising Division